Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D O Clary

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
Leukemia|October 19, 2011
EXEL-8232, a small-molecule JAK2 inhibitor, effectively treats thrombocytosis and extramedullary hematopoiesis in a murine model of myeloproliferative neoplasm induced by MPLW515LG Wernig, M G Kharas, A Mullally, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 1, 1995
TrkA expression in the CNS: evidence for the existence of several novel NGF-responsive CNS neuronsD M Holtzman, J Kilbridge, Y Li, et al.
Neurobiology of Disease|November 1, 1994
NOS induction by NGF in basal forebrain cholinergic neurones: evidence for regulation of brain NOS by a neurotrophinD M Holtzman, J Kilbridge, D S Bredt, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|April 1, 1995
Regulation of TrkA and ChAT expression in developing rat basal forebrain: evidence that both exogenous and endogenous NGF regulate differentiation of cholinergic neuronsY Li, D M Holtzman, L F Kromer, et al.
Cell|July 28, 1995
The carbonic anhydrase domain of receptor tyrosine phosphatase beta is a functional ligand for the axonal cell recognition molecule contactinE Peles, M Nativ, P L Campbell, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 19, 2017
Overall survival analysis of EXAM, a phase III trial of cabozantinib in patients with radiographically progressive medullary thyroid carcinomaM Schlumberger, R Elisei, S Müller, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Leukemia|October 19, 2011
EXEL-8232, a small-molecule JAK2 inhibitor, effectively treats thrombocytosis and extramedullary hematopoiesis in a murine model of myeloproliferative neoplasm induced by MPLW515LG Wernig, M G Kharas, A Mullally, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 1, 1995
TrkA expression in the CNS: evidence for the existence of several novel NGF-responsive CNS neuronsD M Holtzman, J Kilbridge, Y Li, et al.
Neurobiology of Disease|November 1, 1994
NOS induction by NGF in basal forebrain cholinergic neurones: evidence for regulation of brain NOS by a neurotrophinD M Holtzman, J Kilbridge, D S Bredt, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|April 1, 1995
Regulation of TrkA and ChAT expression in developing rat basal forebrain: evidence that both exogenous and endogenous NGF regulate differentiation of cholinergic neuronsY Li, D M Holtzman, L F Kromer, et al.
Cell|July 28, 1995
The carbonic anhydrase domain of receptor tyrosine phosphatase beta is a functional ligand for the axonal cell recognition molecule contactinE Peles, M Nativ, P L Campbell, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 19, 2017
Overall survival analysis of EXAM, a phase III trial of cabozantinib in patients with radiographically progressive medullary thyroid carcinomaM Schlumberger, R Elisei, S Müller, et al.
Pageof 4